FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to cardiology and concerns medical treatment of coronary heart disease (CHD). For this purpose mexicor combined with statins is included in standard system of CHD treatment. Method ensures effective medical treatment and increased physical activity tolerance due to hypocholesteremic action of statins and elimination of their inhibitory effect on enzymes of mitochondrion respiratory chain with mexicor.
EFFECT: increased effective medical treatment and physical activity tolerance.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ISCHEMIC HEART DISEASE | 2010 |
|
RU2438665C1 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2428978C1 |
| METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
| METHOD OF TREATING NON-ALCOHOLIC LIVER DISEASE ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2538221C1 |
| HEPATOPROTECTOR FOR TREATING NON-ALCOHOLIC LIVER DISEASE IN TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2537227C1 |
| APPLICATION OF 2-ETHYL-6-METHYL-3-OXYPYRIDINE SUCCINATE FOR TREATMENT OF NEPHRITIS AND NEPHROPATHY | 2004 |
|
RU2290930C2 |
| METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
| METHOD FOR CORRECTING COGNITIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2555334C1 |
